Donna Cryer

Few liver health advocacy organizations have policy staff or personnel in Washington, DC. To fill this gap, we provide liver health policy updates to report on timely information and actionable updates on activities relevant to liver health, including liver cancer, viral hepatitis, autoimmune liver conditions as well as issues that span conditions, such as coverage or other policy decisions.

The COVID-19 Response Program for Patients features information tailored to the special needs of patients living with pediatric liver disease, rare liver disease, NASH, pre/post liver transplant and liver cancer.

The Congressionally Directed Medical Research Programs’ (CDMRP), Peer Reviewed Cancer Research Program (PRCRP) consumer advocate Steven West recently participated in the evaluation of research applications submitted to the PRCRP.

The COVID-19 Response Program for Patients features information tailored to the special needs of patients living with pediatric liver disease, rare liver disease, NASH, pre & post liver transplant, and liver cancer.

Donna Cryer, CEO and president of the Global Liver Institute, discusses the importance of having diverse clinical trials in cancer care.